Trial Profile
Pilot study on interferon gamma in association with peg-interferon alpha 2a and ribavirin among patients with a chronic hepatitis C and non responders to the association of peg-interferon alpha 2b or 2a and ribavirin ANRS HC16 Gammatri
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon gamma (Primary) ; Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Aug 2007 Status changed from terminated to completed.
- 18 Nov 2005 New trial record.